Myelomatosis: Clinical and laboratory features in Nigerians

West African Journal of Medicine

Volumn 24, Issue 1, 2005, Pages 54-57

  Salawu, L ^a   Durosinmi, M A ^a  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

Clinical features; Myelomatosis; Nigerians; Survival

Indexed keywords

BENCE JONES PROTEIN; M PROTEIN; PARAPROTEIN; PLASMA PROTEIN;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BONE LESION; BONE PAIN; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; ELECTROPHORESIS; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; GAIT DISORDER; HUMAN; HYPERCALCEMIA; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LABORATORY TEST; MALE; MULTIPLE MYELOMA; MUSCLE WEAKNESS; NIGERIA; OSTEOLYSIS; PATHOLOGIC FRACTURE; PLASMACYTOSIS; PROTEINURIA;

EID: 18844418170     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: 10.4314/wajm.v24i1.28164     Document Type: Article

References (25)

1. Lewis DR, Pattern LM, Silverman DT et al: Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation. Cancer Causes and Control. 1994; 5: 529-539.
2. Pottern LM, Gart JJ, Nam JM, et al: HLA and Multiple myeloma among black and white men: evidence of a genetic association. Cancer Epidemiology, Biomarkers and Prevention 1992; 1: 177-182.
3. Kyle RA: Why better prognostic factors for Multiple myeloma are needed. BLOOD. 1994; 83: 1713-1716.
4. Catovsky D, Foa R: The Lymphoid Leukaemias. London. Butterworth. 1990; 277-308.
5. Ameis A, Ko HS, Pruzanski W: M components- a review of 1242 cases. Canadian Medical Association Journal 1976; 114: 889-895
6. Scott GL and Read AE: Haematology: including disorders of lymphoid tissue. In: Modern Medicine: A Textbook for Students. Read AE, Barritt DW, Hewer RL (eds) 2nd ed. London. Pitman. 1982; 402-404.
7. Bourantas K. Non-secreting multiple myeloma. Eur. J. Haematol. 1996; 56: 109-111.
8. Anderson KC, Kyle RA, Berenson JR and Dalton WS: Recent advances in the biology and treatment of multiple myeloma. American Society of Haematology. (Education Programme). 1998; pp 63-88.
9. Choo-Kang E and Campbell M: Biochemical abnormalities in multiple myeloma. West Indian Medical Journal. 1991; 40: 170-172.
10. Spasov E and Goranova V: Prognostic assessment of the Durie and Salmon staging system in patients with multiple myeloma. Folia Medica (Plovdiv). 1998; 40: 121-123.
11. Ucci G, Riccardi A, Luoni R and Ascari E: Presenting features of monoclonal gammopathies: an analysis of 684 newly diagnosed cases. Cooperative Group for the study and treatment of multiple myeloma. Journal of International Medicine. 1993; 243: 165-173.
12. Adam Z, Krahulova M, Spelda SS et al. Therapy of anaemia in patients with multiple myeloma Acta Medica Austriaca 1995; 22: 59-64.
13. Nossent JC, Winkel CN and van Leeuwen JC: Multiple myeloma in the Afro-Caribbean population of Caracao Netherlands Journal of Medicine 1993; 43: 210-214.
14. Blade JK, Lust JA and Kyle RA: Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases. Journal of Clinical Oncology 1994; 12: 2398-2404.
15. Wang GM: Clinical analysis of 25 cases of multiple myeloma. Chinese Journal of Clinical Oncology. 1991; 13: 68-70.
16. Brian GM, Giles D and Giles F: Myelomatosis (Multiple myeloma). In: Hoffbrand AV, Lewis SM, Tuddenham EGD (eds). Postgraduate Haematology. Butterworth-Heinemann. Oxford. 1999. Pp 462-478.
17. Thiran C, Laloux P, Boucquey D, Brucher JM, Dooms G and Doyen C: Intracranial plasmacytoma manifesting as multiple myeloma: apropos of a case. Acta Neurologica Belgica. 1992; 92: 278-288.
18. Sirois DA, Cohen SG and Greenberg MS: Maxillo-facial plasmacytoma resulting in intra-oral haemorrhage in a patient with multiple myeloma. Special Care in Dentistry. 1991; 11: 158-161.
19. Blade J, Kyle RA and Greipp PR: Presenting features and prognosis in 72 patients with multiple myeloma who are younger than 40 years. Br J Haematol 1996; 93: 345-351.
20. Adam Z, Krahulova M, Spelda SS et al. Therapy of anaemia in patients with multiple myeloma Acta Medica Austriaca 1995; 22: 59-64.
21. Beguin Y, Yerna M, Loo M, Weber M and Fillet G: Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production. Br. J. Haematol. 1992; 82: 648-653.
22. Kaushansky K: Multiple myeloma: multiple ways to defeat erythropoiesis. Blood. 2001; 97: 1153.
23. Schey SA and Linch DC: Myeloma and related disorders. In: Ludlam CA (ed.). Clinical Haematology. Educational Low-Priced Books with Churchill Livingstone. Edinburgh. 1990; pp.183-201.
24. Blade J, san Miguel JF and Fontanillas M: Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/auto-transplantation and who were conventionally treated. J. Clin. Oncol. 1996; 14: 2167-2173.
25. Durosinmi MA and Adediran IA. Cancer management under Structural Adjustment Programme (SAP): Experience in Ile-Ife; Nigeria. Nigerian Medical Journal. 1993; 25: 92-96.